Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

STX

Shield Therapeutics (STX)

Shield Therapeutics Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:STX
DateTimeSourceHeadlineSymbolCompany
05/26/20172:01AMUK RegulatoryShield Therapeutics PLC Appointment of Joint BrokerLSE:STXShield Therapeutics Plc
04/28/20172:00AMUK RegulatoryShield Therapeutics PLC Annual Report, Accounts and AGM NotificationLSE:STXShield Therapeutics Plc
04/04/20177:26AMAlliance NewsAlliance NewsShield Therapeutics Appoints CFO As Loss Narrows In 2016LSE:STXShield Therapeutics Plc
04/04/20172:01AMUK RegulatoryShield Therapeutics PLC Appointment of Chief Financial OfficerLSE:STXShield Therapeutics Plc
04/04/20172:00AMUK RegulatoryShield Therapeutics PLC Preliminary Results for the Year Ended 31 Dec 2016LSE:STXShield Therapeutics Plc
03/13/20176:16AMAlliance NewsAlliance NewsShield Therapeutics Gets Australian Patent Covering Feraccru To 2035LSE:STXShield Therapeutics Plc
03/13/20173:01AMUK RegulatoryShield Therapeutics PLC Notice of ResultsLSE:STXShield Therapeutics Plc
03/13/20173:00AMUK RegulatoryShield Therapeutics PLC IP Portfolio UpdateLSE:STXShield Therapeutics Plc
01/30/20175:50AMUK RegulatoryShield Therapeutics PLC Directorate and Secretarial UpdateLSE:STXShield Therapeutics Plc
01/06/20174:53AMAlliance NewsAlliance NewsTAKING AIM: Liberum Confident On Shield Therapeutics' 2017 OutlookLSE:STXShield Therapeutics Plc
01/06/20174:07AMAlliance NewsAlliance NewsShield Therapeutics Sees "Very Encouraging" Demand For FeraccruLSE:STXShield Therapeutics Plc
01/06/20172:00AMUK RegulatoryShield Therapeutics PLC Business UpdateLSE:STXShield Therapeutics Plc
11/07/20164:06AMAlliance NewsAlliance NewsMereo BioPharma Poaches New Finance Chief From Shield TherapeuticsLSE:STXShield Therapeutics Plc
11/07/20162:00AMUK RegulatoryShield Therapeutics PLC Board ChangeLSE:STXShield Therapeutics Plc
09/20/20165:25AMAlliance NewsAlliance NewsShield Therapeutics Reports First Revenue In Maiden Interim ResultsLSE:STXShield Therapeutics Plc
09/20/20162:01AMUK RegulatoryShield Therapeutics PLC Interim Results for six months ended 30 June 2016LSE:STXShield Therapeutics Plc
09/13/20164:25AMUK RegulatoryShield Therapeutics PLC Grant of Share AwardsLSE:STXShield Therapeutics Plc
09/07/20164:02AMAlliance NewsAlliance NewsShield Therapeutics Gets UK Patent On Feraccru Active IngredientLSE:STXShield Therapeutics Plc
09/07/20162:37AMUK RegulatoryShield Therapeutics PLC Composition of Matter Patent Granted on Feraccru®LSE:STXShield Therapeutics Plc
09/07/20162:01AMUK RegulatoryShield Therapeutics PLC Composition of Matter Patent Granted on Feraccru®LSE:STXShield Therapeutics Plc
08/15/20167:22AMUK RegulatoryShield Therapeutics PLC Notice of ResultsLSE:STXShield Therapeutics Plc
08/04/20166:05AMUK RegulatoryShield Therapeutics PLC Result of AGMLSE:STXShield Therapeutics Plc
08/01/20167:00AMRNS Non-RegulatoryShield Therapeutics PLC Presenting at Canaccord Genuity Conference, BostonLSE:STXShield Therapeutics Plc
06/30/201612:06PMUK RegulatoryShield Therapeutics PLC 2015 Annual Report and Accounts and Notice of AGMLSE:STXShield Therapeutics Plc
06/14/20165:17AMAlliance NewsAlliance NewsShield Therapeutics Reports Widened Pretax Loss In Maiden 2015 ResultsLSE:STXShield Therapeutics Plc
06/14/20162:01AMUK RegulatoryShield Therapeutics PLC Maiden Preliminary Results for FY15LSE:STXShield Therapeutics Plc
03/23/20163:01AMUK RegulatoryShield Therapeutics PLC Notice of results and change of accounting dateLSE:STXShield Therapeutics Plc
03/11/20162:01AMUK RegulatoryShield Therapeutics PLC Grant of Share AwardsLSE:STXShield Therapeutics Plc
02/26/20164:17AMAlliance NewsAlliance NewsShield Therapeutics Starts Trading, Gets European Feraccru Approval (ALLIPO)LSE:STXShield Therapeutics Plc
02/26/20163:34AMUK RegulatoryShield Therapeutics PLC First Day of Dealings on AIMLSE:STXShield Therapeutics Plc
 Showing the most relevant articles for your search:LSE:STX